Affimers are revolutionary new engineered affinity proteins that have been designed to address many of the negative performance issues experienced with antibodies such as poor specificity, batch-to-batch variation and the long time taken to generate new custom antibodies.
Affimers are small, robust and very stable. They are not limited by the immune system and are generated without the use of animals. Affimer technology is proprietary to Avacta Life Sciences and therefore licensing is straightforward.
For more information see www.avactalifesciences.com